# John Cunningham (JC) Virus Encephalitis Without Progressive Multifocal Leukoencephalopathy in a Stem Cell Transplant Patient: A Case Report and Literature Review

## TL;DR

A 28-year-old stem cell transplant patient developed JC virus encephalitis, a rare and fatal condition, with atypical brain imaging and no response to treatment.

## Contribution

This case report highlights JC virus encephalitis without PML in a stem cell transplant recipient, emphasizing its rarity and poor prognosis.

## Key findings

- JC virus was detected in both blood and cerebrospinal fluid of the patient.
- Brain imaging showed atypical features of JCV encephalitis without PML-like findings.
- Virus-specific T-cell therapy showed minimal to no clinical benefit in this case.

## Abstract

John Cunningham (JC) Virus (JCV) belongs to the Polyomaviridae family and is notorious for remaining latent in the kidneys and lymphoid organs of healthy populations. However, in the setting of profound immunosuppression, the virus can reactivate, leading to various manifestations depending on its location of infection, i.e., progressive multifocal leukoencephalopathy (PML), JC virus encephalopathy, or JC virus granule cell neuronopathy. Here, we present a unique case of a 28-year-old female with a notable medical history of acute myeloid leukemia (AML) status post stem cell transplant who presented to the emergency department (ED) for evaluation of her altered mental status for one week. Laboratory investigations documented the presence of JCV in both the blood and cerebrospinal fluid (CSF). Unlike the typical findings of PML, the brain imaging revealed a 4 mm T2-weighted fluid attenuated inversion recovery (T2/FLAIR) hyperintense enhancing focus in the right supratentorial region and a right anterior temporal subcortical white matter enhancement measuring up to 14 mm in size with no corresponding FLAIR abnormality suggestive of JCV encephalitis. The patient received virus-specific T cells but showed minimal to no improvement. Hence, the patient's family opted for hospice care, but the patient died subsequently. JCV encephalitis is a relatively rare condition; only a few case reports have been reported. The prognosis of JCV encephalitis is not well established and is most often lethal with high viral loads. Virus-specific T-cell therapy has not yet demonstrated the desired clinical benefit; therefore, additional data are required.